Premium
Letter: response‐guided treatment of hepatitis C virus genotype 5 may be feasible
Author(s) -
Papastergiou V.,
Karatapanis S.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12702
Subject(s) - ribavirin , medicine , genotype , hepatitis c virus , pegylated interferon , epidemiology , hepatitis c , hepacivirus , virology , immunology , virus , biology , gene , biochemistry